Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphomaCody A. Ramirez, Todd A. Fehniger, Felix Frenkel et al.|Blood Advances|2024Cited by 12
Long-Term Follow-up of Bendamustine/Rituximab - Rituximab/Cytarabine (BR/RC) Induction Therapy for Previously Untreated Transplant-Eligible Patients with Mantle Cell Lymphoma (MCL)Christine E. Ryan, Reid W. Merryman, Imran Nizamuddin et al.|Blood|2024Cited by 0